"Sometimes the juice ain't worth the squeeze... especially when combining grapefruit with medicines.
While it can be part of a balanced and nutritious diet, grapefruit can have serious consequences when taken with certain medications. Cu"...
Clinical consequences of overdosage with OptiMARK™ (gadoversetamide injection) Injection have not been reported. Treatment of an overdose is directed toward the support of all vital functions and prompt institution of symptomatic therapy. OptiMARK™ (gadoversetamide injection) Injection has been shown to be dialyzable (see CLINICAL PHARMACOLOGY).
OptiMARK™ (gadoversetamide injection) is contraindicated in patients with:
- chronic, severe kidney disease (glomerular filtration rate, GFR < 30 mL/min/1.73m²), or
- acute kidney injury, or
- known allergic or hypersensitivity reactions to gadolinium, versetamide or any of the inert ingredients.
Last reviewed on RxList: 2/11/2011
This monograph has been modified to include the generic and brand name in many instances.
Additional OptiMARK Information
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Find out what women really need.